Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zai Lab Limited

    NASDAQ: ZLAB · Real-Time Price · USD
    32.58
    -0.05 (-0.15%)
    At close: May 21, 2025, 3:03 PM
    -0.15%
    Bid 32.58
    Market Cap 357.2M
    Revenue (ttm) 418.33M
    Net Income (ttm) -252.07M
    EPS (ttm) -2.5
    PE Ratio (ttm) -13.03
    Forward PE 94.17
    Analyst Buy
    Ask 32.63
    Volume 592,575
    Avg. Volume (20D) 1,265,550
    Open 32.08
    Previous Close 32.63
    Day's Range 32.08 - 33.22
    52-Week Range 16.01 - 39.77
    Beta 1.04

    About ZLAB

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ZLAB
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ZLAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +6.69%
    Zai Lab shares are trading higher on possible cont... Unlock content with Pro Subscription
    2 months ago
    +5.7%
    Zai Lab shares are trading higher after JP Morgan raised its price target on the stock from $44 to $51.
    news image

    2 days ago · businesswire.com

    Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer

    SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZL-1310, the ...

    news image

    1 week ago · seekingalpha.com

    Zai Lab Limited (ZLAB) Q1 2025 Earnings Call Transcript

    Zai Lab Limited (NASDAQ:ZLAB ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Christine Chiou - Senior Vice President, Investor Relations Samantha Du - Founder, Chairpers...

    news image

    1 week ago · zacks.com

    Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say

    Although the revenue and EPS for Zai Lab Limited (ZLAB) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall...

    news image

    1 week ago · businesswire.com

    Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates

    SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the first quarter of 2025, along with recent product highlights and corpo...

    news image

    3 weeks ago · businesswire.com

    Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025

    SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will present new data from studies evaluating two of its internally developed, next-generation, investigational...

    news image

    4 weeks ago · businesswire.com

    Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors

    SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China's National Medical Products Administration (NMPA) has accepted the supplemental New ...

    news image

    1 month ago · zacks.com

    All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy

    Zai Lab Limited (ZLAB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    news image

    1 month ago · zacks.com

    Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last?

    Zai Lab Limited (ZLAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increa...

    news image

    1 month ago · businesswire.com

    Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting

    SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that data from preclinical studies of the Company's internally discovered and developed next-ge...

    news image

    2 months ago · seekingalpha.com

    Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth

    Zai Lab Limited is an innovative Pharma partnering with US and European Pharmas to secure approvals for, and market their drugs in China. ZLAB stock has surged over 105% in the past year, driven by st...

    Add to Watchlist